Research reveals that over a third of people have experienced discrimination at work because of their migraine

Research reveals extent of workplace discrimination due to migraine

NICE approves migraine medication Rimegepant for preventive use on the NHS in England

Unfortunately it has not been approved for acute use

The Migraine Trust Fellowship recipients announced

Neuroscientists awarded fellowships for projects that seek to learn more about the role of hormones in migraine

We welcome the decision by SMC to approve migraine medication Rimegepant for use in NHS Scotland

Approved for the acute treatment of migraine

Migraine News: Issue 126

Read the latest edition of our magazine, Migraine News

NICE has rejected migraine medication Rimegepant for use on the NHS in England

We are very concerned about the unnecessary suffering of people with medication overuse headache and those without effective treatment for their migraine

The SMC approves eptinezumab (Vyepti) to treat episodic and chronic migraine

This follows last month’s NICE approval of it

We welcome the new clinical care pathway for the UK’s 10 million people with migraine

It now needs to be urgently implemented

NICE approves eptinezumab (Vyepti) to treat episodic and chronic migraine

Eligible patients must have access

Two new fellowships launched

Support for early career clinicians or scientists in undertaking migraine research

Susan Haydon Bursary recipient publishes migraine and genetics research

Migraine News: Issue 125

Read the latest edition of our magazine, Migraine News